Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€83.72

€83.72

0.190%
0.16
0.190%
€82.10

€82.10

 
27.07.26 / Tradegate WKN: 934623 / Symbol: MET / Name: MetLife / Stock / Insurance / Large Cap /
Latest predictions
22.07.26
2.65%
buy
€92.90
21.07.26
2.25%
buy
€92.14
13.07.26
1.84%
buy
10.07.26
3.69%
buy
€88.39
09.07.26
4.47%
buy
€89.26
09.07.26
4.47%
buy
Best running prediction
€75.26
26.03.26
37.70%
buy
Your prediction

Metlife Inc. Stock

Metlife Inc. gained 0.190% compared to yesterday.
The stock is an absolute favorite of our community with 35 Buy predictions and no Sell predictions.
On the other hand, the target price of 82 € is below the current price of 83.72 € for Metlife Inc., so the potential is actually -2.05%.
Our community identified positive and negative aspects for Metlife Inc. stock for the coming years. 1 users see the criterium "Expected dividend yield" as a plus for the Metlife Inc. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.

MetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.

AI-generated

Pros and Cons of Metlife Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Metlife Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Metlife Inc. 0.190% 1.509% 12.067% 24.682% 22.395% 49.355% 66.800%
Lincoln National -0.960% -2.763% 12.363% 21.079% -7.019% 44.641% -25.826%
Aflac Inc. 0.630% 1.330% 6.301% 25.483% 18.131% 68.189% 143.768%
Prudential Financial 1.180% 1.345% 12.714% 17.746% 9.553% 20.903% 24.793%

sharewise BeanCounterBot AI-generated

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

MetLife, a prominent company in the insurance industry with the US symbol MET, seems to have a steady footing in terms of its overall financial standing. Glancing at the company's yearly and quarterly financial statements, it is evident that MetLife has a significant asset base and a stable net income. However, a deeper analysis of the company's financials is necessary to understand the pros and cons, which will help assess the company's performance and growth potential.

*Pros: *

Significant asset base: MetLife has a strong asset base, with total assets worth $666.61 billion as of December 31, 2022. This indicates that the company has a vast array of resources to support its operations and generate revenue. With a strong asset base, MetLife can leverage its resources for continued growth and better risk management.

Comments

MetLife (MET) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for MET provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 2.25%
Target price 92.898
Change
Ends at 21.07.27

MetLife (MET) had its price target raised by JPMorgan Chase & Co. from $96.00 to $106.00. They now have an "overweight" rating on the stock.
Ratings data for MET provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 1.84%
Target price 92.138
Change
Ends at 13.07.27

MetLife (MET) had its price target raised by Keefe, Bruyette & Woods from $98.00 to $105.00. They now have an "outperform" rating on the stock.
Ratings data for MET provided by MarketBeat
Show more

News

Higher-for-Longer Rates Are a Gift for Life Insurers. MetLife and Prudential Are Cashing In.: https://g.foolcdn.com/editorial/images/876237/23_11_28-a-person-sitting-across-a-desk-from-two-people-in-a-negotiation-_mf-dload-gettyimages-1477040217-1281x800-141e56b.jpg
Higher-for-Longer Rates Are a Gift for Life Insurers. MetLife and Prudential Are Cashing In.

When interest rates were near historical lows, MetLife (NYSE: MET) and Prudential (NYSE: PRU) had a problem. They had made promises about future payments, but miserly interest rates made it more

Alico Exits Citrus as $650M-$750M Florida Land Portfolio Takes Center StagePhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
Alico Exits Citrus as $650M-$750M Florida Land Portfolio Takes Center Stage

Key Points

These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?Photo, wide shot, wide-angle lens, soft focus,  Reinsurance company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-bSRc7PrRT00tZTDNf9SggMTD.png?st=2023-05-06T18%3A48%3A49Z&se=2023-05-06T20%3A48%3A49Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A38%3A49Z&ske=2023-05-07T00%3A38%3A49Z&sks=b&skv=2021-08-06&sig=3seGuy7NQJX9RXUOWr6XArANokWXlKqwnEJxEHfdbSY%3D
These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?

Key Points